A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery
Condition(s) studied
Investigational drug(s) / intervention(s)
Tubeless laparoscopic adrenalectomy: No drainage tube placed after laparoscopic adrenalectomy
Drainage tube: Placing drainage tubes after laparoscopic adrenalectomy
Study summary
The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are:
1. The safety of tubeless laparoscopic adrenalectomy;
2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.
Eligibility
Primary outcome measure(s)
- Pain score — 1-3 days after surgery
Pain rating scale after laparoscopic adrenalectomy by VAS(visual analog scale for pain ) scale. The score ranges from 1 to 10, and the degree of pain gradually increases. - First time up and about — 1-3 days after surgery
First time up and about after laparoscopic adrenalectomy - Recovery time of intestinal function — 1-3 days after surgery
Recovery time of intestinal function after laparoscopic adrenalectomy - Hematoma — 1-3 days after surgery
Detection of obvious hematoma (Hematoma area\> 4cm x 4cm) in the surgical area through color ultrasound. The results are expressed as yes or no.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Zhongnan hospital | Wuhan | Hubei | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06250699 on ClinicalTrials.gov ↗ ← All trials in China